Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in Neurobiology of Aging
- Vol. 16 (1), 1-4
- https://doi.org/10.1016/0197-4580(95)80001-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The synaptic organization of the neocortex in Alzheimer's diseaseMedical Hypotheses, 1993
- Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's diseaseJournal of Neuroscience, 1993
- A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study GroupJAMA, 1992
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 1992
- Aging brain: effect of acetyl-l-carnitine treatment on rat brain energy and phospholipid metabolism. A study by31P and1H NMR spectroscopyBrain Research, 1990
- Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's diseaseBrain Research, 1987
- The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerationsMechanisms of Ageing and Development, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975